Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2014; 4(10): 058-061


The effects of Balanite aegyptiaca kernel cake as supplement on alloxan-induced diabetes mellitus in rats

M. S. Nadro, F. P. Samson.




Abstract

Diabetes mellitus is one of the disease for which a satisfactory treatment is not available in modern allopathic system of medicine. Therefore, there is a need to develop newer treatment strategies of plant origin as they are known to have fewer side effects. The present study investigated the possible therapeutic effects of Balanite aegyptiaca kernel cake on certain biochemical markers in alloxan-induced diabetes mellitus in rats. Diabetes was induced in albino rats by single intraperitoneal injection of Alloxan (70mg/kg body weight). Normal diet supplemented with 10% and 20% of kernel cake of Balanites aegyptiaca were fed to diabetic rats for three weeks. The effects of the aegyptiaca kernel cake on blood glucose, albumin, urea, creatinine, total cholesterol, triglyceride and the activities of liver marker enzymes aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase were examined in the serum of control and treated groups. Supplementation of Balanites aegyptiaca kernel cake 10% and 20% to diabetic rats for Three weeks significantly reduced blood glucose (451.80 ± 5.4 to 408.60 ± 1.8), urea (429.30±1.10 to 203.40± 4.1), and creatinine (2.05±0.05 to 1.80±0.21) but increased the levels of albumin (3.14±0.07 to 3.50±0.01), and restored all marker enzymes to near normal levels. The present results showed that Balanites aegyptiaca kernel cake has an antihyperglycaemic and antihyperlipidemic effect and consequently may alleviate liver and renal damage associated with Alloxan -induced diabetes mellitus in rats.

Key words: Alloxan, diabetes mellitus, Balanite aegyptiaca, kernel cake, supplementation.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.